FI69465C - Foerfarande foer framstaellning av farmakologiskt aktiva 3,8-dialkylxantiner - Google Patents
Foerfarande foer framstaellning av farmakologiskt aktiva 3,8-dialkylxantiner Download PDFInfo
- Publication number
- FI69465C FI69465C FI811212A FI811212A FI69465C FI 69465 C FI69465 C FI 69465C FI 811212 A FI811212 A FI 811212A FI 811212 A FI811212 A FI 811212A FI 69465 C FI69465 C FI 69465C
- Authority
- FI
- Finland
- Prior art keywords
- ethyl
- dihydro
- purine
- dione
- propyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Claims (4)
1. Förfarande för framstä lining av en f arinako logiskt aktiv förening med formeln il H HN^C\C^ N\ I II C-R2 (I)
0 R1 eller ett fysiologiskt acceptabelt sait därav, i vilken formel 1 R är en etyl-, n-propyl-, n-butyl-, isobutyl-, n-pentyl-, 2-metylbutyl-, 3-metylbutyl-, 2,2-dimetylpropyl-, cyklopropyl-, 2 cyklobutyl-, cyklopentyl- eller cyklohexylmetylgrupp och R är en metyl-, etyl-, n-propyl-, isopropyl-, cyklopropyl-, n-butyl-, isobutyl-, tert.butyl- eller cyklobutylgrupp förutsatt 1 2 att R är en etylgrupp dl R är en metylgrupp, k ä n n e -tecknat av att en förening med formeln /C X HN C-NH, I II 2 0^C'-N-C-NH2 R1 omsättes med en förening med formeln R2-X 1 2 van R och R har ovan angiven betydelse och X är -C00H, -C0NH„ 2. eller -OC-O-CO-R , och vid behov dehydratiseras den erhallna produkten, varefter, om sl önskas, den erhlllna föreningen om- vandlas ti]1 ett fysiologiskt acceptabelt sait.
2. Förfarande enligt patentkravet 1, kännetecknat av att man framställer en förening med formeln P h il n ^CX N HN c \ I li C-CH3 ^c^n^c.xN^·
0 I C2H5
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8002910A SE8002910L (sv) | 1980-04-18 | 1980-04-18 | 3,8-dialkylxantiner, forfarande for deras framstellning, beredning och metoder for behandling av kronisk obstruktiv luftvegssjukdom och kardiovaskulera sjukdomar |
| SE8002910 | 1980-04-18 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI811212L FI811212L (fi) | 1981-10-19 |
| FI69465B FI69465B (fi) | 1985-10-31 |
| FI69465C true FI69465C (fi) | 1986-02-10 |
Family
ID=20340763
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI811212A FI69465C (fi) | 1980-04-18 | 1981-04-16 | Foerfarande foer framstaellning av farmakologiskt aktiva 3,8-dialkylxantiner |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US4546182A (sv) |
| EP (1) | EP0038784B1 (sv) |
| JP (1) | JPS56166191A (sv) |
| AT (1) | ATE10099T1 (sv) |
| AU (1) | AU543122B2 (sv) |
| CA (1) | CA1156229A (sv) |
| DD (1) | DD158400A5 (sv) |
| DE (1) | DE3166893D1 (sv) |
| DK (1) | DK151631B (sv) |
| ES (1) | ES501400A0 (sv) |
| FI (1) | FI69465C (sv) |
| GR (1) | GR82347B (sv) |
| HU (1) | HU185254B (sv) |
| IE (1) | IE51106B1 (sv) |
| NO (1) | NO811161L (sv) |
| NZ (1) | NZ196829A (sv) |
| PH (1) | PH16264A (sv) |
| PL (1) | PL134762B1 (sv) |
| PT (1) | PT72881B (sv) |
| SE (1) | SE8002910L (sv) |
| ZA (1) | ZA811729B (sv) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE7810947L (sv) * | 1978-10-20 | 1980-04-21 | Draco Ab | 3-alkylxanthines |
| US4710503A (en) * | 1985-02-07 | 1987-12-01 | Euroceltique S.A. | 6-thioxanthine derivatives |
| GB8618931D0 (en) * | 1986-08-02 | 1986-09-10 | Euro Celtique Sa | 6-thioxanthines |
| US5298508A (en) * | 1988-07-19 | 1994-03-29 | The United States Of America As Represented By The Department Of Health And Human Services | Irreversible inhibitors of adenosine receptors |
| JP2843634B2 (ja) * | 1989-03-06 | 1999-01-06 | 協和醗酵工業株式会社 | キサンチン誘導体 |
| IT1229195B (it) * | 1989-03-10 | 1991-07-25 | Poli Ind Chimica Spa | Derivati xantinici ad attivita' broncodilatatrice e loro applicazioni terapeutiche. |
| AU5436790A (en) * | 1989-04-19 | 1990-11-16 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | Sulfer-containing xanthine derivatives as adenosin antagonists |
| CA2030112A1 (en) * | 1989-11-24 | 1991-05-25 | Yasuo Ito | Xanthine compound, method for preparing thereof, and a pharmaceutical composition comprising the same |
| US5366977A (en) * | 1992-09-29 | 1994-11-22 | The United States Of America, As Represented By The Department Of Health And Human Services | Method of treating cystic fibrosis using 8-cyclopentyl-1,3-dipropylxanthine or xanthine amino congeners |
| DE4311538C1 (de) * | 1993-04-07 | 1994-10-06 | Boehringer Ingelheim Kg | Verfahren zur Herstellung von 1,3-Dimethyl-4,5-diaminouracil |
| AU6781194A (en) * | 1993-05-03 | 1994-11-21 | United States Of America, Represented By The Secretary, Department Of Health And Human Services, The | 8-substituted 1,3,7-trialkyl-xanthine derivatives as a2-selective adenosine receptor antagonists |
| WO1997037667A1 (en) | 1996-04-10 | 1997-10-16 | The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Use of an a1 adenosine receptor agonist to treat cerebral ischaemia |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS53890B2 (sv) * | 1972-04-22 | 1978-01-12 | ||
| US4089959A (en) * | 1976-03-31 | 1978-05-16 | Cooper Laboratories, Inc. | Long-acting xanthine bronchodilators and antiallergy agents |
| CA1077932A (en) * | 1976-03-31 | 1980-05-20 | Berlex Laboratories, Inc. | Xanthine compounds and method of treating bronchospastic and allergic diseases |
| SE416810C (sv) * | 1977-10-14 | 1982-07-19 | Draco Ab | Forfarande for framstellning av xantinderivat med antiallergisk aktivitet |
| SE7810946L (sv) * | 1978-10-20 | 1980-04-21 | Draco Ab | Metod att behandla kronisk obstruktiv luftvegssjukdom |
| SE7810947L (sv) * | 1978-10-20 | 1980-04-21 | Draco Ab | 3-alkylxanthines |
-
1980
- 1980-04-18 SE SE8002910A patent/SE8002910L/sv not_active Application Discontinuation
-
1981
- 1981-03-09 DE DE8181850039T patent/DE3166893D1/de not_active Expired
- 1981-03-09 EP EP81850039A patent/EP0038784B1/en not_active Expired
- 1981-03-09 AT AT81850039T patent/ATE10099T1/de not_active IP Right Cessation
- 1981-03-16 ZA ZA00811729A patent/ZA811729B/xx unknown
- 1981-03-17 CA CA000373230A patent/CA1156229A/en not_active Expired
- 1981-04-01 PH PH25455A patent/PH16264A/en unknown
- 1981-04-03 NO NO811161A patent/NO811161L/no unknown
- 1981-04-08 IE IE769/81A patent/IE51106B1/en unknown
- 1981-04-14 DD DD81229229A patent/DD158400A5/de unknown
- 1981-04-14 DK DK168281AA patent/DK151631B/da active IP Right Grant
- 1981-04-15 ES ES501400A patent/ES501400A0/es active Granted
- 1981-04-15 NZ NZ196829A patent/NZ196829A/en unknown
- 1981-04-15 GR GR64702A patent/GR82347B/el unknown
- 1981-04-15 AU AU69555/81A patent/AU543122B2/en not_active Ceased
- 1981-04-16 PT PT72881A patent/PT72881B/pt unknown
- 1981-04-16 FI FI811212A patent/FI69465C/fi not_active IP Right Cessation
- 1981-04-17 JP JP5724181A patent/JPS56166191A/ja active Pending
- 1981-04-17 PL PL1981230737A patent/PL134762B1/pl unknown
- 1981-04-17 HU HU811020A patent/HU185254B/hu unknown
-
1983
- 1983-08-16 US US06/523,731 patent/US4546182A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DD158400A5 (de) | 1983-01-12 |
| NZ196829A (en) | 1984-12-14 |
| ES8203088A1 (es) | 1982-02-16 |
| JPS56166191A (en) | 1981-12-21 |
| EP0038784A3 (en) | 1982-01-20 |
| PH16264A (en) | 1983-08-23 |
| HU185254B (en) | 1984-12-28 |
| EP0038784A2 (en) | 1981-10-28 |
| IE51106B1 (en) | 1986-10-01 |
| FI69465B (fi) | 1985-10-31 |
| IE810796L (en) | 1981-10-18 |
| PL230737A1 (sv) | 1982-03-29 |
| SE8002910L (sv) | 1981-10-19 |
| PT72881A (en) | 1981-05-01 |
| PT72881B (en) | 1983-03-29 |
| DK151631B (da) | 1987-12-21 |
| DE3166893D1 (en) | 1984-12-06 |
| DK168281A (da) | 1981-10-19 |
| AU6955581A (en) | 1981-10-22 |
| ZA811729B (en) | 1982-04-28 |
| GR82347B (sv) | 1984-12-13 |
| ES501400A0 (es) | 1982-02-16 |
| FI811212L (fi) | 1981-10-19 |
| CA1156229A (en) | 1983-11-01 |
| US4546182A (en) | 1985-10-08 |
| NO811161L (no) | 1981-10-19 |
| PL134762B1 (en) | 1985-09-30 |
| ATE10099T1 (de) | 1984-11-15 |
| EP0038784B1 (en) | 1984-10-31 |
| AU543122B2 (en) | 1985-04-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0010531B1 (en) | 3-alkylxanthines, processes for their preparation and compositions for use in the treatment of chronic obstructive airway disease and cardiac disease | |
| FI66383C (fi) | Foerfarande foer framstaellning av farmakologiskt aktiva xantinderivat | |
| ES2222614T3 (es) | Derivados de purina y medicina que los contiene como ingrediente activo. | |
| US4804664A (en) | Method and pharmaceutical preparation for treating chronic obstructive airway disease and cardiac disease, and intermediates for the preparation of therapeutically active xanthine derivatives | |
| FI69465C (fi) | Foerfarande foer framstaellning av farmakologiskt aktiva 3,8-dialkylxantiner | |
| US4612315A (en) | Biologically-active 1,3-dipropyl-8-phenylxanthine derivatives | |
| US6310205B1 (en) | Hypoxathine compounds | |
| ES2253881T3 (es) | Inhibidores de quinasa dependiente de ciclinas. | |
| DK161965B (da) | 6-thioxanthiner og salte deraf samt deres fremstilling og anvendelse | |
| HU203755B (en) | Process for producing cyclopenentyl-purine derivatives and pharmaceutical compositions containing them | |
| AU8034800A (en) | Selective antagonists of A2B adenosine receptors | |
| JPH0755949B2 (ja) | 新規ピリド〔２，３−ｄ〕ピリミジン誘導体、その製造方法並びに該化合物を含有する医薬組成物 | |
| JPH02164881A (ja) | 治療用ヌクレオシド化合物 | |
| CN116041349B (zh) | 一种黄嘌呤类化合物及其制备方法和在制备新冠病毒3cl蛋白酶抑制剂中的应用 | |
| HU180321B (en) | Process for producing 6- and 9-substituted 2-amino-purine derivatives | |
| JPS63246378A (ja) | ８−アザキサンチン類、その製法及び医薬組成物 | |
| JPH06293762A (ja) | ピリド〔２，３−ｄ〕ピリミジン誘導体を含有する医薬組成物 | |
| CH670090A5 (sv) | ||
| JPH05262770A (ja) | 化学的製法 | |
| CA2034224A1 (en) | 1-amino-5-halogenouracils, process for their preparation, and central nervous system depressants containing same as active ingredient | |
| CS203095B2 (cs) | Způsob přípravy substituovaných purinů |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed |
Owner name: AKTIEBOLAGET DRACO |